Stock KPTI KARYOPHARM THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Karyopharm Therapeutics Inc.

Equities

KPTI

US48576U1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.15 USD +1.32% Intraday chart for Karyopharm Therapeutics Inc. +7.48% +32.95%
May. 08 Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M MT
May. 08 Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
PR
Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M
MT
Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024
Karyopharm Therapeutics: Q1 Earnings Snapshot
AQ
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
PR
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
PR
Karyopharm Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Karyopharm Therapeutics Inc. Reaffirms Earnings Guidance for the Full Year of 2024
CI
Karyopharm Therapeutics Inc. announced that it expects to receive $100 million in funding
CI
Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
PR
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
AQ
Karyopharm Therapeutics Inc. Announces Presentations in Endometrial Cancer and Myelofibrosis At the 2024 American Society of Clinical Oncology Annual Meeting
CI
Karyopharm Therapeutics : April 19, 2024
PU
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Transcript : Karyopharm Therapeutics Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
PR
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Karyopharm Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KPTI Stock
  4. News Karyopharm Therapeutics Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW